Guneet Bhatia

The U.S. FDA has approved Kanuma as the first line of treatment for patients with a rare enzyme disease called LAL deficiency.

Radiation from Japan's 2011 nuclear disaster has contaminated the previously identified sites along the North American shores, confirm scientists.

Ajanta Pharma has launched its generic Montelukast Sodium tablets for treatment of people with asthma and seasonal allergy in the United States.

A new study suggests that more than 50 percent of the Americans at a greater risk of heart disease because of increased cholesterol levels do not take medications to lower it down.

While authorities in Beijing issued an “orange alert” following the deteriorating outdoor conditions, there is no such formal mechanism to issue an alert in the Indian capital.

A study conducted by researchers at the Hiroshima University suggests that statins can help prevent recurrence of stroke due to larger artery atherosclerosis.

A leading U.K.-based pediatrician has warned that people who overuse paracetamol-based medicines such as Calpol could be putting their children's lives at risk.

The discovery of molecular mechanism associated with destruction of brain cell connections during the onset of dementia could pave the way for more research into possible treatments.

A team of Italian researchers has developed a humanoid robot that can interact with the environment as humans do.

In case they wish to plan late pregnancy, women can now check if they are running out of eggs using the new fertility test.

The development of artificial pancreas by a team of scientists in Colorado could be the next big thing in the treatment of diabetics.

The theft of medical protective equipment from a hospital in the French capital has added to the government's fears of a chemical or biological terror attack.

At least 7 people have been hospitalized downtown after consuming what police called a “bad batch” of synthetic marijuana "Spice."

A new study has discovered that humans share 70 percent of their genes with a deep-sea marine worm called acorn worms.

Tree nuts can help reduce the risk of cardiovascular diseases, suggests a new study conducted by researchers at the Life Sciences Research Organization.

The U.S. Food and Drug Administration has approved Narcan nasal spray for the treatment of opioid overdose.

A new gene in people and animals in China can make the bacteria resistant to almost all classes of antibiotics, suggests a new study.

A team of researchers has developed a screening test that can help detect ovarian cancer at an early stage with a 90 percent accuracy rate.

The U.S. Justice Department has filed criminal charges against the seller of Jack3d workout supplement, USPlabs, and six of its executives for unlawful sales of the supplement.

A new study has suggested that as many as half of the historical specimens preserved in the museums across the world could be wrongly labeled.

Taking a step toward prevention of foodborne illness, the U.S. Food and Drug Administration has finalized the rules that outline the safety standards to be followed by different parties involved in the food production.

Deposition of fat around belly region is even more harmful than being obese, suggests a new study.

A new study looking at the impact of the shrinking snowpacks over the northern hemisphere suggests that over 2 billion people could suffer from water shortage.

The doctors at the Cleveland Clinic aspire to become the first ones to implant a uterus in a woman who do not have one.

The World Health Organization is planning to launch its first-ever global campaign for better use of antibiotics during the World Antibiotic Awareness Week.

Despite umpteen attempts being made to control U.S. obesity, the rate continues to rise, suggests a new study.

The antibiotic used to treat MRSA might actually make it worse, suggests a new study.

The U.S. Food and Drug Administration might soon decide to put a cap on daily sugar intake to help Americans cut down on it.

AstraZeneca's experimental lupus drug anifrolumab showed positive results in Phase II study trials, the drug maker announced Tuesday.